Skip to main content
DNA Labs India

TPM3 Gene Nemaline myopathy type 1 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

TPM3 Gene Nemaline myopathy type 1 NGS Genetic Test

Short Name: TPM3 Gene NGS Genetic Test

Also known as: TPM3-related nemaline myopathy genetic test, Nemaline myopathy type 1 gene test, TPM3 gene sequencing NGS

TPM3 Gene Nemaline myopathy type 1 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One Drop Blood on FTA Card samples. Results in Results will be issued within 3 to 4 weeks after the sample reaches the laboratory.. Free home collection in 300+ cities across India.

NGS Genetic TestAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to detect pathogenic or likely pathogenic variants in the TPM3 gene, which are associated with nemaline myopathy type 1, and to confirm the diagnosis in clinically suspected individuals.

Test Code
4398
Price
₹20,000
Sample Type
Blood or Extracted DNA or One Drop Blood on FTA Card
Result Time
Results will be issued within 3 to 4 weeks after the sample reaches the laboratory.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No special preparation such as fasting is required. A genetic counselling session is recommended before testing to obtain a detailed clinical history and draw a pedigree chart of family members affected with nemaline myopathy. Informed consent should be documented.

Method: Venous blood collection / FTA card blood spot / submitted extracted DNA

Step 2

Laboratory Analysis

A trained phlebotomist will collect a small amount of venous blood. Alternatively, a few drops of blood may be placed on an FTA card. For those providing extracted DNA, the laboratory will confirm the required quantity and quality.

Step 3

Report Delivery

You can return to normal routine immediately. The blood or FTA card sample is transported to the laboratory, and results will be available in 3 to 4 weeks.

Timeline: Results will be issued within 3 to 4 weeks after the sample reaches the laboratory.

Patient Instructions

1
Before the Test:No fasting is required. A genetic counselling session is recommended before testing to review clinical history and draw a pedigree chart of family members affected with TPM3-related nemaline myopathy.
2
During the Test:A blood sample is collected from a vein in the arm. Alternatively, one drop of blood may be placed on an FTA card. No sedation is needed.
3
After the Test:You may resume normal activities immediately. The laboratory will process the sample and provide the report in 3 to 4 weeks.

About This Test

Who Should Get This Test

The purpose of this test is to detect pathogenic or likely pathogenic variants in the TPM3 gene, which are associated with nemaline myopathy type 1, and to confirm the diagnosis in clinically suspected individuals.

How to Prepare

  • No fasting required
  • Blood can be collected in an EDTA tube
  • FTA card blood spot can be used for home collection
  • Bring valid identity proof and referral or clinical notes
  • Genetic counseling and informed consent documentation are required

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"TPM3 genetic testing should be accompanied by detailed clinical and family history. Variant classification needs rigorous review before it is used for clinical decisions."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One Drop Blood on FTA Card
Sample VolumeAs per laboratory protocol
ContainerEDTA tube / FTA card / sterile DNA vial
Collection MethodVenous blood collection / FTA card blood spot / submitted extracted DNA

Sample Stability

Please follow the sample collection kit instructions provided by DNA Labs India
FTA card blood spot should be kept dry
Extracted DNA storage should be as per laboratory protocol
Sample Rejection Criteria:
  • Unlabelled or mislabelled sample
  • Incorrect or expired collection tube
  • Insufficient blood volume or DNA quantity
  • Visible sample leakage or contamination
  • Mismatch between patient details and consent form

Understanding Your Results

Results are interpreted by a clinical geneticist after correlation with the patient's clinical phenotype and family history. Variants are classified as pathogenic, likely pathogenic, variant of uncertain significance, likely benign, or benign.
Positive: Pathogenic or likely pathogenic TPM3 variant detected, consistent with a clinical diagnosis of TPM3-related nemaline myopathy. Genetic counseling and family studies are recommended.
Negative: No pathogenic or likely pathogenic variant detected in TPM3. This does not exclude nemaline myopathy, and other genes or variant types may need evaluation.
Variant of uncertain significance: A DNA change was found, but its effect on protein function is not yet clear. Additional family studies and clinical correlation are needed.
Benign or likely benign: The detected variant is not considered disease-causing and is unlikely to explain the patient's clinical presentation.
⚠️ When to Consult a Doctor:

Consult your neurologist or geneticist if the test result is positive, negative but symptoms persist, or shows a variant of uncertain significance. Seek urgent medical attention if breathing difficulty, feeding problems, or sudden worsening of muscle weakness occurs.

Limitations

  • Standard NGS may not detect all variant types, such as large exon-level deletions or duplications
  • Deep intronic and non-coding regulatory variants in TPM3 are not fully evaluated
  • A negative result does not exclude nemaline myopathy caused by variants in other genes
  • Variant of uncertain significance results may need additional family segregation analysis
  • Variant interpretation can change as new scientific evidence becomes available

Risks & Considerations

  • Mild pain or bruising at the venipuncture site
  • Small risk of infection at the puncture site

Interfering Factors

  • Poor quality or inadequate DNA from the submitted sample
  • Sample contamination or incorrect sample labelling
  • Incomplete clinical information or family history needed for interpretation

Frequently Asked Questions

What is TPM3 gene nemaline myopathy type 1?
Nemaline myopathy type 1 is a rare inherited neuromuscular disorder caused by variants in the TPM3 gene. The TPM3 protein is important for muscle contraction, and changes in this gene can lead to muscle weakness, low tone, and breathing or feeding problems.
How does the NGS genetic test detect TPM3 mutations?
Next-generation sequencing reads the DNA sequence of the TPM3 gene from a blood or extracted DNA sample. The laboratory compares the sequence to a reference sequence to identify disease-causing variants.
Is fasting needed for this test?
No. You do not need to fast. The test can be done at any time of the day.
Which sample types are accepted?
The accepted sample types are blood, extracted DNA, or one drop of blood spotted on an FTA card.
How long will the TPM3 genetic test report take?
Reports are usually provided in 3 to 4 weeks after the sample is received in the laboratory.
What is the cost of the TPM3 gene NGS test at DNA Labs India?
The test price is Rs 20000. DNA Labs India offers free home sample collection in multiple cities across India. The typical market range in India is around INR 20,000 to INR 30,000.
What is a genetic counselling session before testing?
The pre-test genetic counselling session helps the clinician draw a family pedigree and explain the medical implications, inheritance pattern, and possible results of the genetic test.
Will the report include raw data files?
Yes. DNA Labs India provides raw data, FASTQ, and VCF files along with the conclusive clinical test report for transparency.
What does a pathogenic or likely pathogenic result mean?
It means the laboratory identified a variant in TPM3 that is considered consistent with TPM3-related nemaline myopathy. This result should be discussed with your neurologist or geneticist.
What does a negative result mean?
A negative result means no pathogenic variant was found in the TPM3 gene. It does not completely exclude nemaline myopathy because variants may be missed or other genes may be responsible.
Can this test be used for prenatal diagnosis?
This test is intended for diagnostic confirmation in affected individuals. Prenatal testing requires the familial TPM3 variant to be known and must be arranged through a clinical geneticist using a specially validated prenatal protocol.
Is the test covered by health insurance?
Insurance coverage for genetic tests varies by policy and insurer. Confirm your coverage and pre-authorisation requirements before booking; you may also ask your healthcare provider for a referral letter.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.